Synapse - Amanda Ciardiello

Amanda Ciardiello

Research Focus

Former Employee. Medicine; NE Agency Contingent

Recent additions – View all

Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma
Journal Article

Tan, C. R.; Derkach, A.; Nemirovsky, D.; Ciardiello, A.; Diamond, B.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U.; Maclachlan, K.; more...
Blood Cancer Journal (2023)

Fulltext@MSK | Save
Sustained minimal residual disease negativity in multiple myeloma is associated with stool butyrate and healthier plant-based diets
Journal Article

Shah, U. A.; Maclachlan, K. H.; Derkach, A.; Salcedo, M.; Barnett, K.; Caple, J.; Blaslov, J.; Tran, L.; Ciardiello, A.; Burge, M.; more...
Clinical Cancer Research (2022)

Fulltext@MSK | Save
Clinical efficacy of daratumumab (DARA)-based second line therapy after DARAcontaining and DARA-free induction therapies in multiple myeloma: A single center experience
Meeting Abstract

Ciardiello, A.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Lu, S. X.; Patel, D.; Maclachlan, K.; Lahoud, O. B.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Co-authors at MSK

Types of Work

Publications